Prodia StemCell Indonesia (ProSTEM)

Business focus

MedTech, BioTech & Pharma

Description

PT Prodia StemCell Indonesia (ProSTEM), founded in 2010, is a pioneer of cell therapy in Indonesia, holding ISO 9001:2015 and BPOM's GMP (CPOB) certification. Its ACT-PLab facility in Jakarta is among the largest stem-cell processing and storage labs in Asia and has run clinical studies on diabetes and osteoarthritis; investment in its second construction phase exceeded IDR 100 billion.